EDIT · Editas Medicine, Inc.
Market Cap
$496.06M
Shares
153.58M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K | 2026-08-05 | 2026-08-03 | |
| 8-K | 2026-06-18 | 2026-06-17 | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 8-K | 2026-05-26 | — | |
| 8-K | 2026-05-26 | — | |
| 8-K | 2026-05-26 | 2026-05-25 | |
| 8-K | 2026-05-14 | — | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| 8-K | 2026-05-05 | — | |
| DEF 14A | 2026-04-28 | — | |
| 8-K | 2026-04-07 | 2026-04-01 | |
| 8-K | 2026-03-27 | 2026-03-26 | |
| Investor Event Transcript | 2026-03-12 | 2026-03-31 | |
| 10-K | 2026-03-09 | 2025-12-31 | |
| 8-K | 2026-03-09 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-10-09 | — | |
| 8-K | 2025-09-02 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-06-12 | — | |
| 8-K | 2025-06-02 | 2025-05-29 | |
| 8-K | 2025-05-14 | — | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-12 | — | |
| DEF 14A | 2025-04-15 | — | |
| 8-K | 2025-03-20 | 2025-03-18 | |
| 8-K | 2025-03-05 | — | |
| 10-K | 2025-03-05 | 2024-12-31 | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-17 | 2024-12-16 | |
| 8-K | 2024-12-12 | 2024-12-11 | |
| 8-K | 2024-12-10 | 2024-12-06 | |
| 8-K | 2024-11-04 | — | |
| 10-Q | 2024-11-04 | 2024-09-30 | |
| 8-K | 2024-10-22 | — | |
| 8-K | 2024-10-04 | 2024-10-03 | |
| 8-K | 2024-08-07 | — | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-06-27 | — | |
| 8-K | 2024-06-14 | — | |
| 8-K | 2024-05-31 | 2024-05-30 | |
| 8-K | 2024-05-08 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| DEF 14A | 2024-04-16 | — | |
| 8-K | 2024-02-28 | — | |
| 10-K | 2024-02-28 | 2023-12-31 |
Showing 1–50 of 118 filings
Key facts
CIK
1650664
CUSIP
28106W103
13F (30d)
152 filings
152 filers
Visit website
Investor relations